MA50205A - Formulation de nicotine - Google Patents
Formulation de nicotineInfo
- Publication number
- MA50205A MA50205A MA050205A MA50205A MA50205A MA 50205 A MA50205 A MA 50205A MA 050205 A MA050205 A MA 050205A MA 50205 A MA50205 A MA 50205A MA 50205 A MA50205 A MA 50205A
- Authority
- MA
- Morocco
- Prior art keywords
- nicotine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18175640.4A EP3574902A1 (fr) | 2018-06-01 | 2018-06-01 | Formulation de nicotine et mode d'administration |
| PCT/EP2019/064212 WO2019229249A1 (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA50205A true MA50205A (fr) | 2020-07-29 |
| MA50205B1 MA50205B1 (fr) | 2021-09-30 |
Family
ID=62528283
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054714A MA54714A (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
| MA50205A MA50205B1 (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054714A MA54714A (fr) | 2018-06-01 | 2019-05-31 | Formulation de nicotine |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11833145B2 (fr) |
| EP (3) | EP3574902A1 (fr) |
| JP (1) | JP7224375B2 (fr) |
| CN (1) | CN112218637A (fr) |
| AU (2) | AU2019276357B2 (fr) |
| BR (1) | BR112020024088B1 (fr) |
| CA (1) | CA3099940A1 (fr) |
| ES (1) | ES2883799T3 (fr) |
| MA (2) | MA54714A (fr) |
| MX (1) | MX2020012810A (fr) |
| NZ (1) | NZ769793A (fr) |
| PL (1) | PL3684362T3 (fr) |
| SG (1) | SG11202011761XA (fr) |
| WO (1) | WO2019229249A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3574902A1 (fr) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Formulation de nicotine et mode d'administration |
| GB201817859D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
| GB201817868D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
| GB201817867D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
| GB201817863D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
| GB201817865D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
| GB201817860D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolised formulation |
| FR3102041A1 (fr) * | 2019-10-22 | 2021-04-23 | Aroma Sens | Edulcorant pour liquides de cigarette électronique |
| US11589610B2 (en) | 2019-12-15 | 2023-02-28 | Shaheen Innovations Holding Limited | Nicotine delivery device having a mist generator device and a driver device |
| EP3855949A4 (fr) | 2019-12-15 | 2021-08-04 | Shaheen Innovations Holding Limited | Inhalateur de brume ultrasonore |
| KR20220141284A (ko) | 2019-12-15 | 2022-10-19 | 샤힌 이노베이션즈 홀딩 리미티드 | 초음파 미스트 흡입장치 |
| US11730191B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
| US11730193B2 (en) | 2019-12-15 | 2023-08-22 | Shaheen Innovations Holding Limited | Hookah device |
| KR102704091B1 (ko) | 2019-12-15 | 2024-09-09 | 샤힌 이노베이션즈 홀딩 리미티드 | 미스트 흡입장치 |
| US20240148053A9 (en) | 2019-12-15 | 2024-05-09 | Shaheen Innovations Holding Limited | Hookah device |
| US11666713B2 (en) | 2019-12-15 | 2023-06-06 | Shaheen Innovations Holding Limited | Mist inhaler devices |
| EP3856304B1 (fr) | 2019-12-15 | 2023-11-08 | Shaheen Innovations Holding Limited | Nébulisateur à ultrasons |
| KR20220116469A (ko) * | 2019-12-18 | 2022-08-23 | 필립모리스 프로덕츠 에스.에이. | 에어로졸 발생 시스템용 제형 |
| JP2021122237A (ja) * | 2020-02-05 | 2021-08-30 | 日本たばこ産業株式会社 | 液体加熱式の加熱型香味吸引器用の液体組成物 |
| EP4125455A1 (fr) | 2020-03-27 | 2023-02-08 | McNeil AB | Cartouche contenant de la nicotine |
| WO2022129906A1 (fr) * | 2020-12-15 | 2022-06-23 | Shaheen Innovations Holding Limited | Dispositif d'administration de nicotine |
| MA65146B1 (fr) * | 2020-04-06 | 2024-05-31 | Shaheen Innovations Holding Ltd | Dispositifs d'inhalateur de brouillard |
| CN111802686A (zh) * | 2020-07-27 | 2020-10-23 | 湖北中烟工业有限责任公司 | 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟 |
| CN111855866A (zh) * | 2020-08-25 | 2020-10-30 | 甘肃烟草工业有限责任公司 | 一种快速测定烟用添加剂中甲醛的方法 |
| CN113197330A (zh) * | 2021-04-28 | 2021-08-03 | 深圳市博睿生物科技有限公司 | 一种电子烟新型甜味剂及制备方法及应用 |
| IL283002A (en) * | 2021-05-06 | 2022-12-01 | Nicogen Ltd | Nicotine formulations and aerosols |
| CN113912585B (zh) * | 2021-11-09 | 2023-02-24 | 深圳萨特瓦生物科技有限公司 | 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟 |
| US20230188901A1 (en) | 2021-12-15 | 2023-06-15 | Shaheen Innovations Holding Limited | Apparatus for transmitting ultrasonic waves |
| CN116019250A (zh) * | 2022-12-22 | 2023-04-28 | 东莞市吉纯生物技术有限公司 | 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法 |
| WO2024138377A1 (fr) * | 2022-12-27 | 2024-07-04 | 思摩尔国际控股有限公司 | Liquide d'atomisation, atomiseur et dispositif d'atomisation électronique |
| WO2024161313A1 (fr) * | 2023-01-31 | 2024-08-08 | Rai Strategic Holdings, Inc. | Formulations de précurseur d'aérosol stabilisées |
| CN117898466B (zh) * | 2024-02-29 | 2024-09-24 | 深圳市艾斯摩迪斯科技有限公司 | 一种复合尼古丁盐的制备方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| GB2133691B (en) * | 1983-01-21 | 1986-05-21 | Leo Ab | Smoking substitutes for nasal administration |
| CA2231968A1 (fr) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Methode de production d'un medicament a base de nicotine |
| US7767698B2 (en) * | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
| SE0201669D0 (sv) * | 2002-06-03 | 2002-06-03 | Pharmacia Ab | New formulation and use thereof |
| GB0712308D0 (en) * | 2007-06-25 | 2007-08-01 | Kind Group Ltd | An inhalable composition |
| CA3208137A1 (fr) * | 2013-05-06 | 2014-11-13 | Juul Labs, Inc. | Formulations de sel de nicotine pour des dispositifs de generation d'aerosol et methodes connexes |
| MY179801A (en) * | 2013-07-19 | 2020-11-16 | Altria Client Services Llc | Liquid aerosol formulation of an electronic smoking article |
| DE102015117811A1 (de) * | 2015-10-20 | 2017-04-20 | Chv Pharma Gmbh & Co. Kg | Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator |
| EP3574902A1 (fr) * | 2018-06-01 | 2019-12-04 | Yatzz Limited | Formulation de nicotine et mode d'administration |
-
2018
- 2018-06-01 EP EP18175640.4A patent/EP3574902A1/fr not_active Withdrawn
-
2019
- 2019-05-31 BR BR112020024088-5A patent/BR112020024088B1/pt active IP Right Grant
- 2019-05-31 EP EP21174043.6A patent/EP3909581A1/fr active Pending
- 2019-05-31 CN CN201980034986.5A patent/CN112218637A/zh active Pending
- 2019-05-31 CA CA3099940A patent/CA3099940A1/fr active Pending
- 2019-05-31 NZ NZ769793A patent/NZ769793A/en unknown
- 2019-05-31 JP JP2020567039A patent/JP7224375B2/ja active Active
- 2019-05-31 SG SG11202011761XA patent/SG11202011761XA/en unknown
- 2019-05-31 US US17/057,700 patent/US11833145B2/en active Active
- 2019-05-31 WO PCT/EP2019/064212 patent/WO2019229249A1/fr active Application Filing
- 2019-05-31 MA MA054714A patent/MA54714A/fr unknown
- 2019-05-31 PL PL19727687T patent/PL3684362T3/pl unknown
- 2019-05-31 MA MA50205A patent/MA50205B1/fr unknown
- 2019-05-31 EP EP19727687.6A patent/EP3684362B1/fr active Active
- 2019-05-31 AU AU2019276357A patent/AU2019276357B2/en active Active
- 2019-05-31 MX MX2020012810A patent/MX2020012810A/es unknown
- 2019-05-31 ES ES19727687T patent/ES2883799T3/es active Active
-
2023
- 2023-05-08 AU AU2023202855A patent/AU2023202855B2/en active Active
- 2023-10-26 US US18/495,012 patent/US20240050424A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023202855B2 (en) | 2024-08-22 |
| BR112020024088B1 (pt) | 2022-10-11 |
| CN112218637A (zh) | 2021-01-12 |
| EP3684362A1 (fr) | 2020-07-29 |
| MA54714A (fr) | 2021-11-17 |
| SG11202011761XA (en) | 2020-12-30 |
| EP3574902A1 (fr) | 2019-12-04 |
| US11833145B2 (en) | 2023-12-05 |
| AU2019276357B2 (en) | 2023-04-20 |
| BR112020024088A2 (pt) | 2021-02-17 |
| CA3099940A1 (fr) | 2019-12-05 |
| NZ769793A (en) | 2024-05-31 |
| EP3684362B1 (fr) | 2021-06-23 |
| US20240050424A1 (en) | 2024-02-15 |
| US20210196700A1 (en) | 2021-07-01 |
| EP3909581A1 (fr) | 2021-11-17 |
| AU2023202855A1 (en) | 2023-05-25 |
| MX2020012810A (es) | 2022-03-08 |
| PL3684362T3 (pl) | 2021-12-20 |
| WO2019229249A1 (fr) | 2019-12-05 |
| JP2021526147A (ja) | 2021-09-30 |
| MA50205B1 (fr) | 2021-09-30 |
| ES2883799T3 (es) | 2021-12-09 |
| JP7224375B2 (ja) | 2023-02-17 |
| AU2019276357A1 (en) | 2020-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50205A (fr) | Formulation de nicotine | |
| DK3688162T3 (da) | Formuleringer | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| MA50657A (fr) | Formulations de niraparib | |
| DK3498278T3 (da) | Forbindelser til behandling af sygdomme relateret til DUX4-ekspression | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| UA40089S (uk) | Кальян | |
| DK3651736T3 (da) | Langtidsvirkende formuleringer | |
| ES2981302T3 (es) | Formulación líquida de nicotina | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK3697418T3 (da) | Forbedrede formuleringer af bromocriptin | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK3678644T3 (da) | Formuleringer af copanlisib | |
| ES2982022T3 (es) | Formulaciones tópicas de detomidina | |
| DK3400017T3 (da) | Kontinuerlig kompleksering af aktive farmaceutiske ingredienser | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| DK3512518T3 (da) | Buprenophinformuleringer med langvarig frigivelse | |
| DK3173071T3 (da) | Formularing af maropitant | |
| DK3625231T3 (da) | Derivatives of resiquimod | |
| MA43166A (fr) | Formulation de fviii | |
| MA43126A (fr) | Compositions pharmaceutiques de fumarate de diméthyle | |
| DK3773501T3 (da) | Intravaginal formulering | |
| DK3519050T3 (da) | Sammensætninger til behandling af oftalmiske sygdomme | |
| ES1220991Y (es) | Ahumador | |
| UA36697S (uk) | Набір форм для випікання |